Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-04 Purchase | 2024-12-06 4:05 pm | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 25,975 | $3.85 | $100,004 | 25,975 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-24 4:11 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-21 4:11 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | HENSON HEIDI Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 4:06 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 19,480 | $0 | 39,480 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:30 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 230,000 | $0 | 930,000 (Direct) | View |
| 2023-08-31 Equity Swap | 2023-08-31 2:41 pm | N/A N/A | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 316,753 | $0 | 0 (Direct) | View |
| 2023-08-31 Disposition | 2023-08-31 2:41 pm | N/A 2033-01-31 | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 682,843 | $0 | 0 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:11 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | HENSON HEIDI Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 4:34 pm | N/A 2033-06-02 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 700,000 | $0 | 1,170,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:29 pm | N/A 2033-02-01 | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 156,250 | $0 | 156,250 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 4:17 pm | N/A N/A | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2022-09-16 4:48 pm | 2019-07-31 2029-04-08 | LISATA THERAPEUTICS INC. | LSTA | HENSON HEIDI Director | 0 | $0 | 32,028 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 4:12 pm | N/A 2032-09-14 | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-05-06 Option Award | 2022-05-10 6:49 pm | N/A 2032-05-05 | PepGen Inc. | PEPG | HENSON HEIDI Director | 11,667 | $0 | 11,667 (Direct) | View |
Ownership | 2022-05-05 8:30 pm | N/A 2031-08-29 | PepGen Inc. | PEPG | HENSON HEIDI Director | 0 | $0 | 55,009 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:07 pm | N/A 2032-01-31 | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
Ownership | 2021-12-27 5:42 pm | N/A N/A | PARDES BIOSCIENCES INC. | PRDS | HENSON HEIDI Chief Financial Officer | 0 | $0 | 558,346 (Direct) | View |